Compound

Allantoin

ATC Index

Allantoin (D03): Medical Uses & Pharmaceutical Guide

Learn about Allantoin, a dermatological agent for wound healing and skin repair. Dosage, uses, and safety information.

Allantoin wound healing dermatological agent skin repair pharmaceutical compound ATC D03 topical medication
ATC Code: D03
Last updated: Feb 23, 2026
Medical Reference

Looking to order Allantoin?

Browse our catalog for available pharmaceutical products and competitive pricing.

View Products

Allantoin: Comprehensive Pharmaceutical Information

Allantoin is a pharmaceutical compound classified under ATC code D03, designated for dermatological and wound care applications. This naturally occurring chemical compound has been utilized in pharmaceutical formulations for over a century due to its remarkable therapeutic properties in promoting tissue repair and skin regeneration.

What is Allantoin?

Allantoin is an organic compound derived from uric acid metabolism or synthesized chemically. It appears as a white to off-white crystalline powder and is highly soluble in hot water. The compound is widely recognized in pharmaceutical and cosmetic industries as an active ingredient in topical formulations designed to enhance skin health and accelerate healing processes.

Mechanism of Action

The therapeutic efficacy of Allantoin operates through several biological mechanisms:

  • Stimulates fibroblast activity, promoting collagen synthesis
  • Enhances epithelialization and tissue proliferation
  • Exhibits mild antimicrobial properties
  • Reduces inflammation and promotes cellular regeneration
  • Maintains optimal moisture balance in affected tissues

Medical Uses

Allantoin is primarily indicated for dermatological conditions requiring accelerated healing. Clinical applications include:

  • Chronic and acute wound healing
  • Minor cuts, abrasions, and superficial lacerations
  • Pressure ulcers and decubitus ulcers
  • Burn injuries and thermal trauma
  • Post-surgical wound care
  • Dermatitis and inflammatory skin conditions
  • Psoriasis and eczema management

Dosage and Administration

Allantoin is administered exclusively via topical application. Typical pharmaceutical formulations contain concentrations ranging from 0.5% to 2%. The compound is available in creams, ointments, gels, and solution preparations. Application should be performed 1-3 times daily directly to affected areas following gentle cleansing of the skin. Healthcare providers should determine specific dosing protocols based on the severity and nature of the condition being treated.

Side Effects and Safety Profile

Allantoin demonstrates an excellent safety profile with minimal adverse effects reported. Potential side effects are rare but may include:

  • Local irritation or redness at application site
  • Mild allergic reactions in sensitive individuals
  • Contact dermatitis in cases of hypersensitivity

The compound is generally well-tolerated across all age groups and can be safely used during pregnancy and lactation.

Important Warnings and Precautions

While Allantoin is considered safe, certain precautions should be observed. Avoid application to open wounds with signs of severe infection without medical supervision. Discontinue use if allergic reactions or severe irritation develop. Allantoin formulations should not be applied to eyes or mucous membranes. Patients with known hypersensitivity to the compound should avoid use. For extensive wounds or severe skin conditions, professional medical evaluation is recommended prior to treatment initiation.

In conclusion, Allantoin represents a valuable therapeutic option in dermatological care, offering efficacy in wound management with minimal adverse effects.

Contact us on WhatsApp

Chat with our support team instantly on WhatsApp.

WhatsApp Chat on WhatsApp